Literature DB >> 25577277

Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes.

Muttiah Barathan1, Kaliappan Gopal, Rosmawati Mohamed, Rada Ellegård, Alireza Saeidi, Jamuna Vadivelu, Abdul W Ansari, Hussin A Rothan, M Ravishankar Ram, Keivan Zandi, Li Y Chang, Ramachandran Vignesh, Karlhans F Che, Adeeba Kamarulzaman, Vijayakumar Velu, Marie Larsson, Tunku Kamarul, Esaki M Shankar.   

Abstract

Persistent hepatitis C virus (HCV) infection appears to trigger the onset of immune exhaustion to potentially assist viral persistence in the host, eventually leading to hepatocellular carcinoma. The role of HCV on the spontaneous expression of markers suggestive of immune exhaustion and spontaneous apoptosis in immune cells of chronic HCV (CHC) disease largely remain elusive. We investigated the peripheral blood mononuclear cells of CHC patients to determine the spontaneous recruitment of cellular reactive oxygen species (cROS), immunoregulatory and exhaustion markers relative to healthy controls. Using a commercial QuantiGenePlex(®) 2.0 assay, we determined the spontaneous expression profile of 80 different pro- and anti-apoptotic genes in persistent HCV disease. Onset of spontaneous apoptosis significantly correlated with the up-regulation of cROS, indoleamine 2,3-dioxygenase (IDO), cyclooxygenase-2/prostaglandin H synthase (COX-2/PGHS), Foxp3, Dtx1, Blimp1, Lag3 and Cd160. Besides, spontaneous differential surface protein expression suggestive of T cell inhibition viz., TRAIL, TIM-3, PD-1 and BTLA on CD4+ and CD8+ T cells, and CTLA-4 on CD4+ T cells was also evident. Increased up-regulation of Tnf, Tp73, Casp14, Tnfrsf11b, Bik and Birc8 was observed, whereas FasLG, Fas, Ripk2, Casp3, Dapk1, Tnfrsf21, and Cflar were moderately up-regulated in HCV-infected subjects. Our observation suggests the spontaneous onset of apoptosis signaling and T cell exhaustion in chronic HCV disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25577277     DOI: 10.1007/s10495-014-1084-y

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  22 in total

Review 1.  Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Tai Hato; Andrew X Zhu; Dan G Duda
Journal:  Immunotherapy       Date:  2016-02-11       Impact factor: 4.196

Review 2.  Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers.

Authors:  Guoying Zhou; Patrick P C Boor; Marco J Bruno; Dave Sprengers; Jaap Kwekkeboom
Journal:  Br J Cancer       Date:  2021-08-16       Impact factor: 9.075

Review 3.  ILP-2: A New Bane and Therapeutic Target for Human Cancers.

Authors:  Zhiliang Zhang; Siqi Xiang; Ruxia Cui; Hang Peng; Roy Mridul; Mingjun Xiang
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 4.  The Promise of Immunotherapy in the Treatment of Hepatocellular Carcinoma.

Authors:  Anthony El-Khoueiry
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 5.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 6.  Recent advances on T-cell exhaustion in malaria infection.

Authors:  Esaki M Shankar; R Vignesh; A P Dash
Journal:  Med Microbiol Immunol       Date:  2018-06-23       Impact factor: 3.402

7.  Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma.

Authors:  Tom Tan-To Cheung; Philip Chong-Hei Kwok; Stephen Chan; Chin-Cheung Cheung; Ann-Shing Lee; Victor Lee; Hoi-Ching Cheng; Nam-Hung Chia; Charing C N Chong; Tak-Wing Lai; Ada L Y Law; Mai-Yee Luk; Chi Chung Tong; Thomas C C Yau
Journal:  Liver Cancer       Date:  2018-01-25       Impact factor: 11.740

Review 8.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

9.  Peripheral and lung resident memory T cell responses against SARS-CoV-2.

Authors:  Judith Grau-Expósito; Nerea Sánchez-Gaona; Núria Massana; Marina Suppi; Antonio Astorga-Gamaza; David Perea; Joel Rosado; Anna Falcó; Cristina Kirkegaard; Ariadna Torrella; Bibiana Planas; Jordi Navarro; Paula Suanzes; Daniel Álvarez-Sierra; Alfonso Ayora; Irene Sansano; Juliana Esperalba; Cristina Andrés; Andrés Antón; Santiago Ramón Y Cajal; Benito Almirante; Ricardo Pujol-Borrell; Vicenç Falcó; Joaquín Burgos; María J Buzón; Meritxell Genescà
Journal:  Nat Commun       Date:  2021-05-21       Impact factor: 14.919

10.  Distinct plasma immune signatures in ME/CFS are present early in the course of illness.

Authors:  Mady Hornig; José G Montoya; Nancy G Klimas; Susan Levine; Donna Felsenstein; Lucinda Bateman; Daniel L Peterson; C Gunnar Gottschalk; Andrew F Schultz; Xiaoyu Che; Meredith L Eddy; Anthony L Komaroff; W Ian Lipkin
Journal:  Sci Adv       Date:  2015-02       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.